Tandem Diabetes Care Inc (NASDAQ:TNDM) shares, rose in value, with the stock price down by -0.90% to the previous day’s close as strong demand from buyers drove the stock to $35.24.
Actively observing the price movement in the last trading, the stock closed the session at $35.56. Referring to stock’s 52-week performance, its high was $40.74, and the low was $13.82. On the whole, TNDM has fluctuated by -0.17% over the past month.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 845.31M, with a low estimate of 166M and a high estimate of 179.8M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 174.02M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that TNDM’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of TNDM currently trading nearly 5.27% and 15.46% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 59.97, while the 7-day volatility ratio is showing 4.82% which for the 30-day chart, stands at 5.05%. Furthermore, Tandem Diabetes Care Inc (TNDM)’s beta value is 1.11, and its average true range (ATR) is 1.76.
A comparison of Tandem Diabetes Care Inc (TNDM) with its peers suggests the former has fared considerably weaker in the market. TNDM showed an intraday change of -0.90% in last session, and over the past year, it shrunk by -6.03%%.
Data on historical trading for Tandem Diabetes Care Inc (NASDAQ:TNDM) indicates that the trading volumes over the past 3 months, they’ve averaged 1.74 million. According to company’s latest data on outstanding shares, there are 65.55 million shares outstanding.
Nearly 0.68% of Tandem Diabetes Care Inc’s shares belong to company insiders and institutional investors own 111.27% of the company’s shares. The stock has risen by 19.13% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the TNDM stock heading into the next quarter.
